06 September 2018
Article in SciTech Europa Quarterly 27, 2018
Beactica's CEO, Dr Per Källblad, explains how the company’s specialist small molecule drug discovery platform is developing a novel therapy for glioblastoma.
Read full article here.
See all recent coverage
Sign up for the Beactica newsletter to receive our latest news and updates